Authors
Loading...
Treatment with STING agonists improves immune responses and reduces HBV replication in mice, suggesting potential for chronic hepatitis B therapy.
Wang et al. (2025) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: